COMMUNIQUÉS West-GlobeNewswire

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
07/05/2024
Conference call begins at 4:30 p.m. Eastern time today MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024 [...]
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
07/05/2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients [...]
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
07/05/2024
DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe [...]
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
07/05/2024
MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, [...]
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
07/05/2024
Collaboration aims to create novel digital PCR assay to improve successful results in DNA analysis from human samples for use in forensics and human identification // DNA quantification enables law enforcement and [...]
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability
07/05/2024
First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First Quarter Adjusted EBITDA [...]
ResMed Announces Participation in the RBCCM Global Healthcare Conference
07/05/2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez, Chief Medical Officer, and Amy Wakeham, Chief Investor Relations Officer, will participate in a fireside chat at [...]
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
07/05/2024
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
07/05/2024
Reported U.S. DANYELZA® net product revenues of $ 18.6 million for the first quarter of 2024, representing a YoY increase of 11% Reported Worldwide DANYELZA net product revenues of $19.4 million for the first quarter of [...]
Treace Medical Concepts Reports First Quarter 2024 Financial Results
07/05/2024
PONTE VEDRA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
ClearPoint Neuro Reports First Quarter 2024 Results
07/05/2024
First Quarter Revenue Growth +41%; Record Revenue Achieved SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling [...]
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
07/05/2024
Highlights: First quarter revenue of $202 million grew 12% year-over-year, driven by Prenatal ( 22% ), Pharmacogenomics ( 21% ), and Hereditary Cancer ( 16% ). First quarter average revenue per test improved by 2% over [...]
SIGA Reports Financial Results for Three Months Ended March 31, 2024
07/05/2024
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 Million Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: [...]
Goodness Growth Holdings Announces First Quarter 2024 Results
07/05/2024
– Q1 2024 revenue of $21.1 million excluding discontinued operations and NY increased 44.5% year-over-year – – Submitted a substantial legal filing on May 2nd in the ongoing litigation with Verano – – Company announces [...]
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2024
07/05/2024
DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
07/05/2024
Inspire Reports Year-over-Year Revenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ( [...]
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
07/05/2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
07/05/2024
Company Announcement COPENHAGEN, Denmark; May 7, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,959 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
07/05/2024
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in key roles including business [...]

Pages